C-8TN3epigenetic editing, gene activation, programmable therapies
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Apply coordinated epigenetic control of disease-network nodes to Alzheimer’s disease as an age-related disease indication.
Programmable, multiplexed epigenetic editors for locus-specific modulation of gene expression networks.
Alzheimer’s is cited on the site as an example age-related disease focus; no candidate, target set, or development stage is disclosed.
Develop programmable therapies that coordinate locus-specific control of multiple disease-network genes for age-related diseases.
Multiplexed epigenetic editors designed to rewrite expression of multiple genes at once through coordinated, locus-specific gene-expression control.
Company site describes the platform and lists a pipeline section, but no individual assets or development stages are disclosed.
Develop programmable therapies that can rewrite expression of multiple genes at once for complex age-related diseases such as Alzheimer's disease and sarcopenia.
Coordinated, locus-specific epigenetic control of disease-network nodes using multiplexed epigenetic editors and programmable gene activation.
Company website describes the platform as its core therapeutic approach and links it to age-related disease targets including Alzheimer's disease and sarcopenia.
Develop next-generation therapies using programmable epigenetic gene activation.
Platform partnership applying General Control's programmable epigenetic gene activation approach with Novo Nordisk.
Site analysis and public records mention Novo Nordisk backing or partnering with General Control around programmable epigenetic gene activation.
Develop next-generation therapies using programmable epigenetic gene activation.
Platform partnership applying programmable epigenetic gene activation technology.
Site mentions a platform partnership with Novo Nordisk; no disease target, asset name, or stage is disclosed.
Apply coordinated epigenetic control of disease-network nodes to sarcopenia as an age-related disease indication.
Programmable, multiplexed epigenetic editors for locus-specific modulation of gene expression networks.
Sarcopenia is cited on the site as an example age-related disease focus; no candidate, target set, or development stage is disclosed.